Back
75· Active
Health & Science1d 18h ago
The FDA granted accelerated approval to Tagrisso combined with chemotherapy for adult patients with locally advanced or metastatic EGFR-mutated lung cancer.
Silver Spring, Maryland, USA
Who
U.S. Food and Drug Administration (FDA) / AstraZeneca
What
The FDA granted accelerated approval to Tagrisso combined with chemotherapy for adult patients with locally advanced or metastatic EGFR-mutated lung cancer.
When
Sun, 07 Jun 2026 15:20:05 GMT · 1d 18h ago
Where
Silver Spring, Maryland, USA · 39.0350°N, 76.9950°W
Why
Clinical data showed a 38% reduction in the risk of disease progression or death compared to monotherapy in the FLAURA2 trial.
The Frontline Impact
How this affects you
This expands treatment options for patients with specific genetic lung cancer profiles, potentially extending progression-free survival significantly.
Story chain
1 event in this threadNo related history yet — this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.